Latest in FAIM
iiiiiiiii
January 31, 2024
AiCure use AI to track patient behavior and enable remote patient participation in clinical studies. Through remote patient involvement and evaluations, AiCure increases research timeline predictability, lowers costs, and speeds timeframes.
January 31, 2024
AI-assisted endoscopy is rapidly evolving, with systems like ENDOANGEL and GI Genius improving colonoscopy accuracy and adenoma detection rates...
January 31, 2024
Taiwanese companies like Medtronic, iXensor, Quanta Computer, Taiwan Main Orthopedics, Health2Sync, and Lumosa integrate AI into healthcare...
January 31, 2024
The efficient and accurate interpretation of radiologic images is paramount.
January 31, 2024
CUE1, a device for patients with Parkinson's disease, has demonstrated positive effects on the mobility & safety of users. Studies have supported the effectiveness of this combination in reducing the freezing of gait episodes in Parkinson's disease patients.
January 31, 2024
Logic and Non-Logic based AI have divergently evolved to master techniques and methods that allow them each to tackle unique challenges...
January 31, 2024
BenevolentAI, the largest private AI company in Europe, is a unique enterprise that uses deep learning advantages to accelerate drug discovery and bring effective medicines to every patient...
January 30, 2024
The vast advancement in the field of AI during 2023 makes for a promising 2024, where an intersection of AI and the world's top medical systems will pave the way to a future where data-driven insights catalyze a paradigm shift in healthcare delivery...
December 30, 2023
In Italy, pioneering AI firms like Newronika and Restorative Neurotechnologies spearhead transformative healthcare solutions. INTA's lab-on-a-chip technology detects analytes, while Euleria focuses on motion analysis. Endostart innovates gastrointestinal endoscopy with magnetic technology...
Expert Interview
Dr. Sameer Mehta
Editor-In Chief & Founder
Sameer Mehta, MD, FACC, MBA, is a U.S. interventional cardiologist
Journal Club
Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer from Biopsy Specimens
JAMA Network Open – Oncology – May 13, 2020
SIGN UP FOR OUR NEWSLETTER
Join our subscribers list to get the latest news and updates directly in your inbox.
From Our Book
